Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-408-2 | CAS number: 527-09-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
DL50 (Oral): 1709 mg/kg bw; OECD 401
DL50 (Dermal): 2130 mg/kg bw; QSAR prediction
CL50 (inhalation): in accordance with column 2 of REACH Annex VIII, the study does not need to be conducted since exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or dorplets of an inhalable size.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Specific details on test material used for the study:
- The test substance was dissolved in tap water and administered in a single dose using a stomach cannula
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- SPF-quality, randomly bred
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Fourty young adult rats of the Wistar strain (SPF-quality, randomly bred) were obtained from the Broekman Institute, Someren, The Netherlands. Date of arrival at the animal house: 21-8-1984 (Dose range finding investigation) and 11-9-1984 and 18-9-1984 (Main study).
From that date on, the animals were individually housed in Macrolon cages. They had free access to tap water and standard laboratory animal diet (RMH-B, pellet diameter 10 mm), which was obtained from Hope Farms, Woerden, The Netherlands. Four days before the start of the main study the animals were randomly distributed into 3 groups with approximately equal distribution of weights. At the start of the study the body weights of the males ranged from 263 to 351 g and those of the females from 174 to 202 g. The animal room temperature was maintained at 20 +-3°C and the relative humidity at 50 - 80 per cent. The artificial light sequence was 12 hours light, 12 hours dark. Feed was withheld overnight before dosing till 4 hours after administration of the test substance. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Based on the sponsor's acute toxicity data on related metal gluconates and literature data on copper salts a pilot study was performed in order to determine a dose range. Groups of one female and one male rat received a single oral dose of the test substance in tap water: 320, 560, 1000, 1800 and 3200 mg/kg body weight.
The dosage volume amounted to 10 ml/kg body weight. Both high dose animals (3200 mg/kg) and one female adminstered 1800 mg/kg died within approximately 24 hours of dosing.
The animals of the other treatment groups revealed no symptomsof systemic toxicity during the 7-day observation period. - Doses:
- The following doses have been administered: 1800, 2400, 3200 mg/kg bw. The dosage volume amounted to 10 ml/kg bw.
- No. of animals per sex per dose:
- Groups of 5 male and 5 female
- Control animals:
- not specified
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 709 mg/kg bw
- Remarks on result:
- other: The LD50 value was calculated according to the 'maximum likelihood' method of Finney (reference 3).
- Mortality:
- All animals of the high dose group died within 24 hours of dosing. Eight out of ten animals of the medium dose group and five out of ten animals of the low dose group were found dead within 48 hours of administration of the test substance.
- Clinical signs:
- other: Most animals showed apathetic behaviour and reduced locomotive activity during a 4-hour period after dos ing. These symptoms did no longer appear in the surviving animals from day 4 of the observation period.
- Gross pathology:
- Examination of the stomach from animals found dead revealed local haemorrhages (petechiae) and necrosis in the fundus. Moreover, the entire intestinal tract of these animals was congested. All surviving animals showed no treatment rel ated gross al terations during autopsy at the end of the 14-day observation period.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The calculated LD50 value for males and females together amounted to 1709 mg/kg body weight. Substance is classified as a Acute tox (Oral) 4.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 709 mg/kg bw
- Quality of whole database:
- The study is a GLP compliant and has Klimisch score 1.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Guideline:
- other: REACH guidance on QSAR R6
- Specific details on test material used for the study:
- SMILE: OCC{P-}(O)C{P-}(O)C{P+}(O)C{P-}(O)C(=O)O{-}.[Cu]{+}
- Key result
- Dose descriptor:
- LD50
- Effect level:
- 2 130 mg/kg bw
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- DL50= 2130 mg/kg. Substance does not classify as Acute Toxic Dermal in any category.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 130 mg/kg bw
- Quality of whole database:
- Toxicity of the target chemical (2.13E+03 mg/kg) is predicted by QSAR "Modelo QSAR 180404 DL50 Dermica Gluconato".The target chemical FALLS within applicability domain of the prediction. Reliability 2.
Additional information
Justification for classification or non-classification
The oral LD50 was between 300 and 2000 mg/kg bw. Therefore, the substance is classified as Acute Tox. Cat. 4 (Oral)
The dermal LD50 was 2130 mg/kg bw. Therefore, the substance is not classified as Acute Tox (Dermal).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.